This is Part II of the Post that began here in which we discuss the three important suits filed this summer by supplement lawyer Jonathan Emord challenging FDA administrative action on first amendment grounds. The cGMP Challenge – FDA Overreaching? The FDA supplement cGMP regulations were anticipated from the time that DSHEA was passed in [...]

Supplement lawyer Jonathan Emord has filed three important suits this summer challenging FDA administrative action on first amendment grounds.  The suits were all filed on behalf of long-time Emord clients Durk Pearson, Sandy Shaw, the Alliance for Natural Health, and the Coalition to End FDA and FTC Censorship. The complaints in all three cases were [...]

GUEST POST by Jennifer Diaz The United States Food and Drug Administration (FDA) has authority to put an importer, manufacturer, shipper, grower, geographic area of a country, or an entire country on a “detention without physical examination” (DWPE) list  (a/k/a the FDA’s ‘Black List’).  To check if a company you are doing business with is [...]

If you have not visited the NutriSupLaw blog in a little while, you should. To celebrate the start of our fifth year, we gave the blog a makeover. Or as they say on the Web, a redesign. We think the new look does a better job of displaying blog entries and organizing our growing lists of resources, links and tags.

The confusion surrounding steroid use in professional baseball has taken another strange turn. The Associated Press and New York Times report that eight of the 104 players who tested positive for steroids in 2003 fall into another category.

The FDA has put supplement companies on notice that violators can expect earlier detection and prosecution. The agency has shifted to a policy of less talk and more action. The industry response must be to get better or get out.